An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)

This study has been completed.
Sponsor:
Information provided by:
Genentech
ClinicalTrials.gov Identifier:
NCT00097240
First received: November 19, 2004
Last updated: August 2, 2010
Last verified: August 2010

November 19, 2004
August 2, 2010
January 2005
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00097240 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)
The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy

The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Pregnant women solicited through advertising, physician and patient awareness, and other programs.

  • Psoriasis
  • Pregnancy
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
18
September 2009
Not Provided

Any patient who has used Raptiva within 6 weeks prior to conception or during her pregnancy may be included in the Registry. Enrollment is based on Raptiva exposure, whether inadvertent or deliberate, in relation to pregnancy. Enrollment should occur as early as possible during the pregnancy and must occur prior to knowledge of pregnancy outcome.

Female
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00097240
ACD3100g
Not Provided
Disclosures Group, Genentech, Inc.
Genentech
Not Provided
Study Director: Ivor Caro, M.D Genentech
Genentech
August 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP